Core Scientific (CORZ) Capital Expenditures (2021 - 2026)

Core Scientific (CORZ) has 6 years of Capital Expenditures data on file, last reported at $389.2 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 363.47% year-over-year to $389.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 1132.65% YoY), and the FY2025 full-year result was $729.0 million, changed N/A from the prior year.
• Capital Expenditures rose to $389.2 million in Q1 2026, from $279.2 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $389.2 million in Q1 2026 to a low of -$66.2 million in Q4 2024.
• A 5-year average of $86.1 million and a median of $18.9 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures tumbled 532.11% in 2024 and jumped 247408.16% in 2025, its largest moves.
• Tracing CORZ's Capital Expenditures over 5 years: stood at $5.2 million in 2022, then soared by 194.63% to $15.3 million in 2023, then plunged by 532.11% to -$66.2 million in 2024, then surged by 521.81% to $279.2 million in 2025, then soared by 39.38% to $389.2 million in 2026.
• Business Quant data shows CORZ's Capital Expenditures at $389.2 million in Q1 2026, $279.2 million in Q4 2025, and $244.5 million in Q3 2025.